Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role
Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.
Related Resources
Toolkits/Methodology
How to write a constructive, information-rich comment that clearly communicates and supports its claims to have an impact on regulatory decision…
Issue Brief
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
White Papers
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the s
Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Issue Brief
This learning lab covers alarm safety management in the health care supply chain field.